Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010

This publication has 45 references indexed in Scilit:

• Look before You Leap: Active Surveillance for Multidrug-Resistant Organisms
  Clinical Infectious Diseases, 2007
• Anti-MRSA β-lactams in development, with a focus on ceftobiprole: the first anti-MRSA β-lactam to demonstrate clinical efficacy
  Expert Opinion on Investigational Drugs, 2007
• Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
  The Lancet, 2006
• Antimicrobial Resistance in Gram-Positive Bacteria
  The American Journal of Medicine, 2006
• Controlling methicillin-resistant Staphylococcus aureus : Quantifying the effects of interventions and rapid diagnostic testing
  Proceedings of the National Academy of Sciences, 2006
• Dalbavancin: A New Option for the Treatment of Gram-Positive Infections
  Annals of Pharmacotherapy, 2006
• MRSA—the tip of the iceberg
  Clinical Microbiology and Infection, 2006
• Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens
  Diagnostic Microbiology and Infectious Disease, 2005
• Meticillin-resistant Staphylococcus aureus
  The Lancet Infectious Diseases, 2005
• Necrotizing Fasciitis Caused by Community-Associated Methicillin-ResistantStaphylococcus aureusin Los Angeles
  New England Journal of Medicine, 2005